Sort
172,184 grants matching “inflammation”
Immune cell targeting of corticosteroids transforms the treatment of severe, chronic inflammatory diseases
$990,946Jay L Rothstein · Immunext, Inc. · R44 · FY2021 · AI
Cellular Biology Of Host/parasite Interactions
$990,905Ted Hackstadt · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Murine models of vascular remodeling
$990,870Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2010 · HL
IMMUNOGENETIC MECHANISMS OF EXPERIMENTAL CROHN'S DISEASE
$990,850University Of Virginia Charlottesville · P01 · FY2001 · DK
Depleting Circulating Galectin-3 with Therapeutic Apheresis: A NovelTreatment for Sepsis/AKI
$990,810Isaac Eliaz · Eliaz Therapeutics, Inc. · R44 · FY2023 · GM
Consortium for the Longitudinal Evaluation of African Americans With Early Rheuma
$990,583Jr, S. Louis Bridges · University Of Alabama At Birmingham · N01 · FY2009 · HL
A Topical Non Steroidal Anti-inflammatory for Rosacea
$990,578Edwardo Eddie Perez · Signum Biosciences · R44 · FY2012 · AI
Fungal Exposure in NYC Homes Damaged by Hurricane Sandy and Respiratory Outcomes
$990,465Matthew S Perzanowski · Columbia University Health Sciences · U01 · FY2013 · TP
Diagnostic array for aseptic encephalitis
$990,390Darrell P Chandler · Akonni Biosystems, Inc. · R44 · FY2015 · AI
Role of Lifespan Intervention on the Regulation and Progression of Alzheimer's Disease
$990,311Stacey J Rizzo · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · AG
Mechanisms Of Activation Of NF-kappaB, A Mediator Of The Immune Response
$990,237Ulrich Siebenlist · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
HRS Yrs 29-34: Covid Antibody Revision
$990,154David R. Weir · University Of Michigan At Ann Arbor · U01 · FY2022 · AG
Inflammation, Viral Replication, and Atherosclerosis in Treated HIV Infection
$990,050Priscilla Y. Hsue · University Of California, San Francisco · R01 · FY2012 · HL
Microglial, Inflammatory and Omics Markers of Cerebral Small Vessel Disease in the CHARGE Consortium
$989,999Sudha Seshadri · University Of Texas Hlth Science Center · UH3 · FY2019 · NS
Nuclear receptors: action, functions, and roles in disease
$989,992Anton M Jetten · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
PDE4B Inhibitors For Treating Major Depression
$989,992Mark E Gurney · Tetra Discovery Partners, Inc. · R44 · FY2014 · MH
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$989,984Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2021 · NS
Mass Spectrometry Quantitation
$989,919Leesa Deterding · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Identification and Characterization of Signaling Pathways and Mediators Regulating Mast Cell-Related Disorders
$989,897Ana Olivera · National Institute Of Allergy And Infectious Diseases · ZIA · FY2024 · AI
A multi-scale approach to airway hyperresponsiveness: from molecule to organ
$989,697Michael J. Sanderson · Univ Of Massachusetts Med Sch Worcester · R01 · FY2010 · HL
HEU outcomes: population-evaluation and screening strategies (HOPE)
$989,559Grace C John-Stewart · University Of Washington · R33 · FY2024 · HD
Lipolysis during sleep and cardiometabolic consequences of sleep apnea
$989,508Jonathan C. Jun · Johns Hopkins University · R01 · FY2021 · HL
AsthmaNet: Brigham and Women's Hospital & Children's Hospital Boston
$989,393Elliot Israel · Brigham And Women'S Hospital · U10 · FY2012 · HL
AsthmaNet: Brigham and Women's Hospital & Children's Hospital Boston
$989,393Elliot Israel · Brigham And Women'S Hospital · U10 · FY2013 · HL
Alterations In Pulmonary Immune Function And Host Resistance In COX Null Mice
$989,244Darryl C Zeldin · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES